TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
Title:
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
Author:
Schimmer, Roman R. Kovtonyuk, Larisa V. Klemm, Nancy Fullin, Jonas Stolz, Sebastian M. Mueller, Jan Caiado, Francisco Kurppa, Kari J. Ebert, Benjamin L. Manz, Markus G. Boettcher, Steffen